Key points are not available for this paper at this time.
Abstract: Many different diseases and conditions are treated using the Alstonia scholaris (L.) R.Br. plant, which belongs to the Apocynaceae family and is traditionally used to treat asthma, wounds, tumors, skin illnesses, rheumatism, TB, malaria, leprosy, hepatitis, gonorrhea, cough, cold, and gastrointestinal problems. This study integrates scientific evidence with pharmacolog-ical, phytochemical, and folkloric claims from Alstonia scholaris (L.) R.Br. papers and literature. The literature on Alstonia scholaris (L.) R.Br. was compiled by a systematic search of globally recognized scientific research databases, including Scopus, PubMed, Springer, Web of Science, and Science Direct. In order to gain knowledge about the history and applications of the plant in these domains, traditional and supplementary reference materials were also utilized. Alstonia scholaris (L.) R.Br. contains several bioactive alkaloids. The species has been proven to have several pharmacological effects in-vivo and in-vitro. Scientific investigations have revealed that this substance has potential as a medicine for a variety of medical conditions, including diabetes, inflammation, pain, asthma, hepatoprotection, immunomodulation, infertility, wound healing, central nervous system stimulation, ulcers, cancer, and helminths. It is required to carry out more pharmacological studies because there are insufficient pharmacological activity data for a num-ber of the isolated components of Alstonia scholaris. The present evaluation provides promise for future research and bridges the research gap on its many facets. The vast spectrum of phar-macological actions is attributed to alkaloids, triterpenes and triterpenoides, glucosides, and es-sential oils.
Dhakad et al. (2024) studied this question.